Guidance for DPIA Practices: A New Whitepaper for EU-Funded Projects
As health research becomes increasingly data-driven, ensuring robust data protection and ethical handling of sensitive information is more important than ever. When dealing with technologies like Federated Learning and cross-border data sharing, the risks to privacy grow, and so does the need for clear, actionable guidance. To address this, ONCOVALUE is proud to have contributed […]
Tracking Cancer Over Time: ONCOVALUE’s Unique Annotated Dataset
ONCOVALUE has developed a unique annotated dataset to train an AI-based imaging tool designed to support the assessment of metastatic breast cancer. With Siemens Healthineers leading its development, the tool ultimately aims to help evaluate which therapies are effective by providing objective, image-based information on disease progression. Using longitudinal medical imaging data (i.e. imaging data […]
ONCOVALUE Joins the Cancer Survivorship – Artificial Intelligence Working Group (CS-AIW) Cluster
We are excited to announce that ONCOVALUE has officially joined the Cancer Survivorship – Artificial Intelligence Working Group (CS-AIW) cluster, a European initiative focused on advancing cancer research through the application of artificial intelligence (AI). The CS-AIW cluster brings together European projects dedicated to improving cancer outcomes. Through collaboration and shared expertise, this cluster aims […]
ONCOVALUE Consortium Meeting – March 2025
The fourth ONCOVALUE consortium meeting took place on March 4-5, 2025, in Copenhagen, Denmark. It was a pleasure to see familiar faces as consortium partners gathered to discuss the progress of the project. A special thank you to Rigshospitalet for hosting and providing an excellent setting for productive discussions. Over two days, participants had the […]
